Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Meagher

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Cancer Cell|November 13, 2019
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In VivoLongchuan Bai, Haibin Zhou, Renqi Xu, et al.
Scientific Reports|January 13, 2021
Targeted disruption of pi-pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activityEvelyn M Covés-Datson, Steven R King, Maureen Legendre, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Discovery of a potent and selective c-Kit inhibitor for the treatment of inflammatory diseasesNing Chen, Roland W Bürli, Susana Neira, et al.
Journal of Medicinal Chemistry|November 21, 2019
Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 ProteinHaibin Zhou, Longchuan Bai, Renqi Xu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 28, 2020
Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2Kyung Soo Park, Joseph D Bazzill, Sejin Son, et al.
Journal of Medicinal Chemistry|January 2, 2025
Discovery of SMD-3236: A Potent, Highly Selective and Efficacious SMARCA2 Degrader for the Treatment of SMARC4-Deficient Human CancersLin Yang, Wenbin Tu, Lingying Leng, et al.
Journal of Medicinal Chemistry|January 24, 2020
Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 ProteinsKarson J Kump, Lei Miao, Ahmed S A Mady, et al.
Journal of Medicinal Chemistry|July 18, 2018
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain InhibitorYujun Zhao, Bing Zhou, Longchuan Bai, et al.
Journal of Medicinal Chemistry|May 2, 2008
Discovery of aryl aminoquinazoline pyridones as potent, selective, and orally efficacious inhibitors of receptor tyrosine kinase c-KitEssa Hu, Andrew Tasker, Ryan D White, et al.
ACS Chemical Biology|November 1, 2016
Molecular Mechanism for Isoform-Selective Inhibition of Acyl Protein Thioesterases 1 and 2 (APT1 and APT2)Sang Joon Won, Dahvid Davda, Kristin J Labby, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Cancer Cell|November 13, 2019
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In VivoLongchuan Bai, Haibin Zhou, Renqi Xu, et al.
Scientific Reports|January 13, 2021
Targeted disruption of pi-pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activityEvelyn M Covés-Datson, Steven R King, Maureen Legendre, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Discovery of a potent and selective c-Kit inhibitor for the treatment of inflammatory diseasesNing Chen, Roland W Bürli, Susana Neira, et al.
Journal of Medicinal Chemistry|November 21, 2019
Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 ProteinHaibin Zhou, Longchuan Bai, Renqi Xu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 28, 2020
Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2Kyung Soo Park, Joseph D Bazzill, Sejin Son, et al.
Journal of Medicinal Chemistry|January 2, 2025
Discovery of SMD-3236: A Potent, Highly Selective and Efficacious SMARCA2 Degrader for the Treatment of SMARC4-Deficient Human CancersLin Yang, Wenbin Tu, Lingying Leng, et al.
Journal of Medicinal Chemistry|January 24, 2020
Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 ProteinsKarson J Kump, Lei Miao, Ahmed S A Mady, et al.
Journal of Medicinal Chemistry|July 18, 2018
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain InhibitorYujun Zhao, Bing Zhou, Longchuan Bai, et al.
Journal of Medicinal Chemistry|May 2, 2008
Discovery of aryl aminoquinazoline pyridones as potent, selective, and orally efficacious inhibitors of receptor tyrosine kinase c-KitEssa Hu, Andrew Tasker, Ryan D White, et al.
ACS Chemical Biology|November 1, 2016
Molecular Mechanism for Isoform-Selective Inhibition of Acyl Protein Thioesterases 1 and 2 (APT1 and APT2)Sang Joon Won, Dahvid Davda, Kristin J Labby, et al.
Pageof 15